MTNB logo

MTNB

Profile

Full Name

Matinas BioPharma Holdings, Inc.

Ticker Symbol

MTNB

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 21, 2014

Indexes

Not included

Website

http://www.matinasbiopharma.com

Employees

32

Key Details

Price

$0.56(-2.59%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.10M(-65.62% YoY)

Annual EPS

-$5.50(-10.00% YoY)

PE ratio

-

Next earnings date

Apr 17, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.56
MTNB price is $0.56

30-Day Relative Volume

0.84
MTNB 30-day relative volume is 0.84

Price Performance

Price Most recent change

-2.59%
MTNB price was down -2.59% on Apr 16, 2025

Price YTD change

+10.78%
MTNB price is up +10.78% since January 1st

Price 1-year change

-94.11%
MTNB price is down -94.11% year-on-year

Price 3-year change

-98.76%
MTNB price is down -98.76% over the past 3 years

Price Range

Price All-time high

$194.00
MTNB price is currently -99.71% below its historical high of $194.00

Price 3-year low

$0.11
MTNB price is currently +413.64% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.87M
MTNB market capitalization is $2.87 million

Market cap 3-year change

-98.54%
MTNB market capitalization is down -98.54% over the past 3 years

Market cap All-time high

$376.89M
MTNB market capitalization is currently -99.24% below its historical high of $376.89 million

Market cap sector rank

8.47%
MTNB market capitalization is higher than 8.47% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.41%
MTNB shares outstanding is up +1.41% year-on-year

Shares Outstanding 3-Year Change

+17.28%
MTNB shares outstanding is up +17.28% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.72
MTNB beta is 0.72

200-day SMA

$2.71
MTNB price is currently -79.14% below its 200-day simple moving average

50-day SMA

$0.57
MTNB price is currently -0.14% below its 50-day simple moving average

RSI

52.04
MTNB 14-day relative strength index is 52.04

Volume

0.84
MTNB 30-day relative volume is 0.84

ATR

$0.05
MTNB average true range is $0.05

10-day Historical Volatility

64.35%
MTNB 10-day historical volatility is 64.35%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.10M
MTNB annual revenue is $1.10 million

Revenue Analysts estimate

-
MTNB annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-65.62%
MTNB annual revenue is down -65.62% year-on-year

Revenue Sector rank

12.99%
MTNB annual revenue is higher than 12.99% of companies in Healthcare sector

EPS

EPS

-$5.50
MTNB annual earnings per share is -$5.50

EPS Analysts estimate

-$4.06
MTNB annual earnings per share is currently +35.47% higher than the consensus analysts' forecast

EPS 1-year change

-10%
MTNB annual earnings per share is down -10% year-on-year

EPS Sector rank

17.93%
MTNB annual earnings per share is higher than 17.93% of companies in Healthcare sector

Profit

Gross profit

-
MTNB annual gross profit value is unknown

Gross margin

-
MTNB annual gross profit margin value is unknown

Operating profit

-$23.77M
MTNB annual operating income is -$23.77 million

Operating margin

-2168.43%
MTNB annual operating profit margin is -2168.43%

Net income

-$22.94M
MTNB annual net profit is -$22.94 million

Net margin

-2093.25%
MTNB annual net profit margin is -2093.25%

Expenses

Total expenses

$24.86M
MTNB annual total expenses is $24.86 million

Operating expenses

$24.86M
MTNB annual total operating expenses is $24.86 million

Cost of goods sold

-
MTNB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$10.37M
MTNB annual SGA is $10.37 million

Depreciation and amortization

$941.00K
MTNB annual depreciation & amortization is $941.00 thousand

Interest expense

-
MTNB annual interest expense value is unknown

Income tax

-
MTNB annual income tax value is unknown

EBIT & EBITDA

EBIT

-$23.77M
MTNB annual earnings before interest & taxes is -$23.77 million

EBITDA

-$22.82M
MTNB annual EBITDA is -$22.82 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$25.10M
MTNB annual total assets is $25.10 million

Non current assets

$9.56M
MTNB annual long term assets is $9.56 million

Current assets

$15.54M
MTNB annual total current assets is $15.54 million

Cash and cash equivalents

$4.79M
MTNB annual cash & cash equivalents is $4.79 million

Accounts receivable

-
MTNB annual accounts receivable value is unknown

Inventory

-
MTNB annual inventory value is unknown

Liabilities

Total liabilities

$5.86M
MTNB annual total liabilities is $5.86 million

Long term liabilities

$3.24M
MTNB annual total long term liabilities is $3.24 million

Current liabilities

$2.62M
MTNB annual total current liabilities is $2.62 million

Accounts payable

$514.00K
MTNB annual accounts payable is $514.00 thousand

Debt

Total debt

$3.56M
MTNB annual total debt is $3.56 million

Total debt 1-year change

-13.77%
MTNB annual total debt is down -13.77% year-on-year

Long term debt

$2.90M
MTNB annual long term debt is $2.90 million

Short term debt

$661.00K
MTNB annual short term debt is $661.00 thousand

Equity & Capital

Shareholders equity

$19.25M
MTNB annual stockholders equity is $19.25 million

Book value

$19.25M
MTNB annual book value is $19.25 million

Retained earnings

-$175.57M
MTNB annual retained earnings is -$175.57 million

Working capital

$12.92M
MTNB annual working capital is $12.92 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$15.28M
MTNB annual cash flow from operations is -$15.28 million

Cash from operations 1-year change

+20.24%
MTNB annual cash flow from operations is up +20.24% year-on-year

Cash from investing

$13.24M
MTNB annual cash flow from investing activities is $13.24 million

Cash from investing 1-year change

+171.52%
MTNB annual cash flow from investing activities is up +171.52% year-on-year

Cash from financing

-$7000.00
MTNB annual cash flow from financing activities is -$7000.00

Cash from financing 1-year change

-108.86%
MTNB annual cash flow from financing activities is down -108.86% year-on-year

CAPEX

CAPEX

$218.00K
MTNB annual capital expenditures is $218.00 thousand

CAPEX 1-year change

-75.56%
MTNB annual capital expenditures is down -75.56% year-on-year

Free Cash Flow

Free cash flow

-$15.50M
MTNB annual free cash flow is -$15.50 million

Free cash flow 1-year change

+22.71%
MTNB annual free cash flow is up +22.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
MTNB annual gross profit margin value is unknown

Operating margin

-2168.43%
MTNB annual operating profit margin is -2168.43%

Net margin

-2093.25%
MTNB annual net profit margin is -2093.25%

ROA & ROE

ROA

-65.62%
MTNB annual return on assets is -65.62%

ROE

-82.11%
MTNB annual return on equity is -82.11%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MTNB price to earnings ratio value is unknown

PE ratio Sector rank

-
MTNB price to earnings ratio is unknown

PB Ratio

PB ratio

0.18
MTNB price to book ratio is 0.18

PB ratio Sector rank

19.03%
MTNB price to book ratio is higher than 19.03% of companies in Healthcare sector

PS Ratio

PS ratio

-
MTNB price to sales ratio value is unknown

PS ratio Sector rank

-
MTNB price to sales ratio is unknown

Enterprise value

Enterprise value

-$4.35M
MTNB enterprise value is -$4.35 million

Enterprise value Sector rank

6.85%
MTNB enterprise value is higher than 6.85% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.21
MTNB EV/EBITDA is 0.21

EV/EBITDA Sector rank

68.96%
MTNB EV/EBITDA is higher than 68.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.93
MTNB annual current ratio is 5.93

Quick ratio

-
MTNB annual quick ratio value is unknown

Leverage

Debt to equity

0.00
MTNB annual debt to equity ratio is 0.00

Interest coverage ratio

-
MTNB annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
MTNB piotroski f-score value is unknown

Altman Z-Score

-11.96
MTNB altman z-score is -11.96

Analyst ratings

Recent major analysts updates

Oct 31, 24 Maxim Group
Hold
Jan 31, 23 HC Wainwright & Co.
Buy
Aug 13, 20 Aegis Capital
Buy
Jan 27, 20 Piper Sandler
Overweight
Jan 24, 20 SunTrust Robinson Humphrey
Buy
Jun 26, 19 HC Wainwright & Co.
Buy
Jun 26, 19 H.C. Wainwright
Buy
May 17, 19 BTIG Research
Buy
May 17, 19 BTIG
Buy
Feb 11, 19 Roth Capital
Buy

Institutional Ownership

Similar stocks

ONVO logo
Organovo Holdings (ONVO)
SPRC logo
SciSparc (SPRC)
Catheter Precision (VTAK)
SNPX logo
Synaptogenix (SNPX)
REVB logo
Revelation Biosciences (REVB)
GLMD logo
Galmed Pharmaceuticals (GLMD)
TTOO logo
T2 Biosystems (TTOO)
ADTX logo
Aditxt (ADTX)
TLIS logo
Talis Biomedical (TLIS)
  • What is the ticker symbol for Matinas BioPharma Holdings?
  • Does Matinas BioPharma Holdings pay dividends?
  • What sector is Matinas BioPharma Holdings in?
  • What industry is Matinas BioPharma Holdings in?
  • What country is Matinas BioPharma Holdings based in?
  • When did Matinas BioPharma Holdings go public?
  • Is Matinas BioPharma Holdings in the S&P 500?
  • Is Matinas BioPharma Holdings in the NASDAQ 100?
  • Is Matinas BioPharma Holdings in the Dow Jones?
  • When was Matinas BioPharma Holdings's last earnings report?
  • When does Matinas BioPharma Holdings report earnings?
  • Should I buy Matinas BioPharma Holdings stock now?

What is the ticker symbol for Matinas BioPharma Holdings?

The ticker symbol for Matinas BioPharma Holdings is NYSE American:MTNB

Does Matinas BioPharma Holdings pay dividends?

No, Matinas BioPharma Holdings does not pay dividends

What sector is Matinas BioPharma Holdings in?

Matinas BioPharma Holdings is in the Healthcare sector

What industry is Matinas BioPharma Holdings in?

Matinas BioPharma Holdings is in the Biotechnology industry

What country is Matinas BioPharma Holdings based in?

Matinas BioPharma Holdings is headquartered in United States

When did Matinas BioPharma Holdings go public?

Matinas BioPharma Holdings's initial public offering (IPO) was on July 21, 2014

Is Matinas BioPharma Holdings in the S&P 500?

No, Matinas BioPharma Holdings is not included in the S&P 500 index

Is Matinas BioPharma Holdings in the NASDAQ 100?

No, Matinas BioPharma Holdings is not included in the NASDAQ 100 index

Is Matinas BioPharma Holdings in the Dow Jones?

No, Matinas BioPharma Holdings is not included in the Dow Jones index

When was Matinas BioPharma Holdings's last earnings report?

Matinas BioPharma Holdings's most recent earnings report was on Nov 13, 2024

When does Matinas BioPharma Holdings report earnings?

The next expected earnings date for Matinas BioPharma Holdings is Apr 17, 2025

Should I buy Matinas BioPharma Holdings stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page